These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 6971678)
41. The protease-antiprotease balance within the human lung: implications for the pathogenesis of emphysema. Gadek JE; Pacht ER Lung; 1990; 168 Suppl():552-64. PubMed ID: 2117164 [TBL] [Abstract][Full Text] [Related]
42. Alpha 1-antitrypsin, emphysema and smoking. Carrell RW N Z Med J; 1984 May; 97(756):327-8. PubMed ID: 6610142 [No Abstract] [Full Text] [Related]
43. Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. Gadek JE; Fells GA; Zimmerman RL; Rennard SI; Crystal RG J Clin Invest; 1981 Oct; 68(4):889-98. PubMed ID: 6169740 [TBL] [Abstract][Full Text] [Related]
44. [A study of antielastase activity in the development of pulmonary emphysema in a family with alpha 1-antitrypsin deficiency]. Kishi F; Kakinoki A Nihon Kyobu Shikkan Gakkai Zasshi; 1989 May; 27(5):565-70. PubMed ID: 2615095 [TBL] [Abstract][Full Text] [Related]
45. Extracellular elastolytic activity in human lung lavage: a comparative study between smokers and non-smokers. Smith SF; Guz A; Cooke NT; Burton GH; Tetley TD Clin Sci (Lond); 1985 Jul; 69(1):17-27. PubMed ID: 3905206 [TBL] [Abstract][Full Text] [Related]
46. Antileucoprotease in the airways and emphysema. Dijkman JH Monaldi Arch Chest Dis; 1995 Oct; 50(5):383-7. PubMed ID: 8541823 [TBL] [Abstract][Full Text] [Related]
47. Cigarette smoke inhalation decreases alpha 1-antitrypsin activity in rat lung. Janoff A; Carp H; Lee DK; Drew RT Science; 1979 Dec; 206(4424):1313-4. PubMed ID: 316187 [TBL] [Abstract][Full Text] [Related]
48. [Experimental pulmonary emphysema in rats. Inflammatory phenomena and progression of lung damage]. Borzone G; Ramírez B; Reyes T; Moreno R; Lisboa C; González S Rev Med Chil; 1998 Oct; 126(10):1153-60. PubMed ID: 10030085 [TBL] [Abstract][Full Text] [Related]
49. Opportunities for the specific therapy of destructive lung disease. Gadek JE; Keogh BA; Crystal RG Bull Eur Physiopathol Respir; 1980; 16 Suppl():389-98. PubMed ID: 6971680 [No Abstract] [Full Text] [Related]
50. Opportunities for the development of specific therapeutic agents to treat emphysema. Cohen AB Am Rev Respir Dis; 1979 Oct; 120(4):723-7. PubMed ID: 389114 [No Abstract] [Full Text] [Related]
51. Potential adverse effects of lung macrophages and neutrophils. Cohen AB Fed Proc; 1979 Nov; 38(12):2644-7. PubMed ID: 227753 [No Abstract] [Full Text] [Related]